0001140361-18-003650.txt : 20180129 0001140361-18-003650.hdr.sgml : 20180129 20180129184312 ACCESSION NUMBER: 0001140361-18-003650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180125 FILED AS OF DATE: 20180129 DATE AS OF CHANGE: 20180129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liang Samuel M. CENTRAL INDEX KEY: 0001618037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 18557126 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2018-01-25 0 0000722723 HANGER, INC. HGR 0001618037 Liang Samuel M. 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 Executive Vice President* Common Stock 2018-01-25 4 A 0 20666 0 A 97958 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 72231 72231 D Performance Share Units 2020-05-19 Common Stock 28892 28892 D Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2015 and ending on December 31, 2015. These performance shares if earned vest in equal tranches over a four year period, commencing on the first anniversary of the grant date. Because the Compensation Committee did not certify the attainment of the performance targets until January 25, 2018, the first two tranches were not deemed vested until that date. The remainder of the performance shares will vest in equal installments in March 2018 and March 2019. Includes (i) unvested restricted shares and fully vested shares totaling 20,666 shares of stock from an initial grant of 20,666 shares of restricted stock, half of which vested on January 25, 2018 and the remainder of which will vest on March 7, 2018 and 2019; (ii) unvested restricted shares which total 22,500 shares of stock from an initial grant of 22,500 shares of restricted stock that begins to vest on March 8, 2018; (iii) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (iv) unvested restricted shares and fully vested shares totaling 22,500 shares of stock from an initial grant of 22,500 shares of restricted stock that begins to vest on March 7, 2017; (v) unvested restricted shares and fully vested shares totaling 13,777 shares of stock from an initial grant of 13,777 shares of restricted stock made on March 6, 2015 [continued in next footnote] and (vi) unvested restricted shares and fully vested shares totaling 13,515 shares of stock from an initial grant of 14,745 shares of restricted stock made on May 19, 2014. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number. * The reporting person is Executive Vice President of Hanger, Inc. and President and Chief Operating Officer of Hanger Prosthetics & Orthotics, Inc. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Samuel M. Liang 2018-01-29